Dengue Virus Infection Amongst Patients With Acute Febrile Illness

Launched by TANGERANG DISTRICT HOSPITAL · Feb 8, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding dengue virus infection in patients who are experiencing acute fever in Tangerang Regency, Indonesia. Researchers want to learn more about the symptoms, immune responses, and types of the dengue virus affecting patients. This information will help improve diagnosis and treatment for those with dengue.

To participate in the study, patients must be at least 4 years old and have a fever lasting less than a week, along with at least one dengue-like symptom such as headache, nausea, or rash. Participants will be asked to give their consent, and if they meet the study criteria, they will be monitored and evaluated. This study is currently recruiting participants, and it aims to gather crucial data that could enhance our understanding of dengue fever and aid in better healthcare practices in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients age ≥ 4 years old with fever (≥ 37.5°C), history of fever with antipyretic use, lasting less than or equal to 7 days
• * Presence at least one of the following dengue-like symptoms:
• • Headache
• • Retro-orbital pain
• • Nausea/ vomiting
• • Muscle, bone, or joint pain
• • Rash or bleeding manifestations
• • Patient or patient's guardian giving consent to participate in the study
• Exclusion Criteria:
• • Have a condition that may interfere with study procedures and compliance (based on doctor's assessment)
• • Suspected of focal infection